Advertisement
Advertisement
DHR
Danaher Corporation
165.83
USDSponsored
-0.43
-0.26%
May 13, 14:59 UTC -4
Open
DHR Earnings Reports
Positive Surprise Ratio
DHR beat 38 of 41 last estimates.
93%
Next Report
Date of Next Report
Jul 20, 2026
Estimate for Q2 26 (Revenue/ EPS)
$6.15B
/$1.85
Implied change from Q1 26 (Revenue/ EPS)
+3.37%
/-10.19%
Implied change from Q2 25 (Revenue/ EPS)
+3.63%
/+2.78%
Danaher Corporation earnings per share and revenue
On Apr 21, 2026, DHR reported earnings of 2.06 USD per share (EPS) for Q1 26, beating the estimate of 1.95 USD, resulting in a 5.31% surprise. Revenue reached 5.95 billion, compared to an expected 6.06 billion, with a -1.75% difference. The market reacted with a -0.49% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 19 analysts forecast an EPS of 1.85 USD, with revenue projected to reach 6.15 billion USD, implying an decrease of -10.19% EPS, and increase of 3.37% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Viatris Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.51
Actual
$0.59
Surprise
+15.17%
PACS Group, Inc.
Report Date
May 11, 2026 For Q1 26
Estimate
$0.40
Actual
$0.50
Surprise
+22.55%
Caris Life Sciences, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.02
Actual
$0.00
Surprise
+100.00%
Progyny, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.30
Actual
$0.28
Surprise
-4.89%
Enhabit, Inc.
Report Date
May 13, 2026 For Q1 26
Estimate
$0.15
Actual
-Surprise
-
COMPASS Pathways Plc - ADR
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.38
Actual
-$0.30
Surprise
+22.20%
The Oncology Institute, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.02
Surprise
+74.46%
SkinHealth Systems Inc. Class A Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.05
Surprise
+36.47%
DocGo Inc. Common Stock
Report Date
May 11, 2026 For Q1 26
Estimate
-$0.09
Actual
-$0.12
Surprise
-26.05%
NeuroOne Medical Technologies Corporation Common Stock
Report Date
May 12, 2026 For Q2 26
Estimate
-$0.23
Actual
-$0.25
Surprise
-8.13%
FAQ
What were Danaher Corporation's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Danaher Corporation reported EPS of $2.06, beating estimates by 5.31%, and revenue of $5.95B, -1.75% below expectations.
How did the market react to Danaher Corporation's Q1 2026 earnings?
The stock price moved down -0.49%, changed from $195.50 before the earnings release to $194.54 the day after.
When is Danaher Corporation expected to report next?
The next earning report is scheduled for Jul 20, 2026.
What are the forecasts for Danaher Corporation's next earnings report?
Based on 19
analysts, Danaher Corporation is expected to report EPS of $1.85 and revenue of $6.15B for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement